BIO has announced the BIOEquality Agenda, which aims to attack the systemic inequality, injustice, and unfair treatment of women and communities of color through the positive force of biotechnology. BIO is challenging our industry and our partners to find solutions.
BioCT is proud to participate in this program and encourages all of our member companies to do the same. Overtime we will post testimonials from our companies on their efforts to Promote, Invest and Expand programs to drive positive change.
Be a changemaker, so that all patients can have equal access to health care, education, and job opportunities.
Dawn Hocevar
President & CEO
BioCT